Investor Summit Virtual Conference
Logotype for Nano-X Imaging Ltd

Nano-X Imaging (NNOX) Investor Summit Virtual Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Nano-X Imaging Ltd

Investor Summit Virtual Conference summary

25 Mar, 2026

Company overview and product strategy

  • Provides an end-to-end imaging solution from scan to diagnosis, aiming to enhance diagnostic capabilities for patients.

  • Core product is the Nanox.ARC, a digital multi-source 3D tomosynthesis imaging system, with both first and second generation devices (ARC and ARC X) FDA-cleared.

  • Recent acquisition of VasoHealthcare IT expands the AI and software division, integrating PACS and teleradiology offerings.

  • Commercialization began in the U.S. in 2023, with European commercialization starting in 2024; direct and indirect sales models in the U.S., indirect (distributor) model elsewhere.

  • Focuses on imaging centers, urgent care, orthopedic, and multipurpose clinics to avoid direct competition with larger industry players.

Technology and innovation

  • Proprietary silicon-based, low-voltage, nanoscale cold cathode chip powers the imaging devices, offering cost and operational advantages over traditional X-ray technology.

  • Second generation tubes use glass instead of ceramic, reducing size and complexity; devices are compact, lightweight, and require minimal installation space.

  • Multi-source, multi-axis design enables rapid 3D imaging with lower radiation and power requirements compared to CT.

  • Cloud-based reconstruction software creates 3D images from 30-60 2D scans in under 12 seconds.

  • Devices are easy to operate, maintain, and integrate with existing PACS systems; remote monitoring and updates are provided.

AI and software solutions

  • AI tools are FDA and CE approved, supporting early detection of asymptomatic chronic diseases and preventative management.

  • AI division offers solutions for coronary artery calcium scoring, spinal measurement (HealthOST), bone mineral density, and liver disease detection.

  • Largest AI customer is Spectrum Health, now in its fifth year; new B2B2C models are being piloted with diagnostic centers.

  • Acquisition of VasoHealthcare IT enables cross-selling of PACS software and a more comprehensive solution suite.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Nano-X Imaging